News

Summary: Unlike most tissues, the retina doesn’t summon neutrophils—the body’s typical first responders—when injured. Instead ...
During most eye infections or injuries, neutrophils, immune cells found in the blood, are usually the first line of defense.
During most eye infections or injuries, neutrophils, immune cells found in the blood, are usually the first line of defense. However, researchers at ...
Annexon has completed enrollment in its phase 3 ARCHER II trial of vonaprument (formerly ANX007) for dry age-related macular ...
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...
As more people live longer, doctors are seeing an increase in the number of people with age-related eye problems.
In today's tech-driven lifestyle, most of us spend countless hours staring at screens — whether it's for work, study, or ...
To mark Ophthalmology Times' 50th anniversary, we invited top experts to reflect on the most significant innovations in ...
Lawrence Sincich, Ph.D. Lawrence Sincich, Ph.D., professor at the University of Alabama at Birmingham School of Optometry was ...
With a solid reputation for excellence, Arora Eye Centre has rightfully earned the title of the Best Eye Hospital in Karnal ...
Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical firm pioneering therapies delivered through the suprachoroidal ...
Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that ...